Rachel Nadif

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort.

Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort.

Journal: Thorax

Published: August 07, 2026

Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.

Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.

Journal: The World Allergy Organization journal

Published: March 17, 2026

The occupational exposome and new-onset COPD: longitudinal analyses of two European cohorts.

The occupational exposome and new-onset COPD: longitudinal analyses of two European cohorts.

Journal: Annals of work exposures and health

Published: March 13, 2026

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.

Journal: Clinical and translational allergy

Published: March 12, 2026

Functional dyspnea as an early marker of vulnerability to persistent physical symptoms in the CONSTANCES population-based cohort.

Functional dyspnea as an early marker of vulnerability to persistent physical symptoms in the CONSTANCES population-based cohort.

Journal: Journal of psychosomatic research

Published: February 22, 2026

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Journal: Allergy

Published: January 22, 2026

Exhaled 3-nitrotyrosine is associated with non-allergic asthma in adults from the EGEA study.

Exhaled 3-nitrotyrosine is associated with non-allergic asthma in adults from the EGEA study.

Journal: Free radical biology & medicine

Published: January 14, 2026

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: October 06, 2025

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Journal: Allergy

Published: August 02, 2025

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Journal: Allergy

Published: July 17, 2025

Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

Journal: Occupational and environmental medicine

Published: April 17, 2025

Decrease in Eosinophil-Derived-Neurotoxin With Mepolizumab Is Associated With Asthma Improvement.

Decrease in Eosinophil-Derived-Neurotoxin With Mepolizumab Is Associated With Asthma Improvement.

Journal: Allergy

Published: March 21, 2025

Showing 1-12 of 115

Last Updated: 09/26/2026